KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Return on Equity (2018 - 2025)

Bionano Genomics' Return on Equity history spans 7 years, with the latest figure at 0.81% for Q3 2025.

  • For Q3 2025, Return on Equity rose 129.0% year-over-year to 0.81%; the TTM value through Sep 2025 reached 0.81%, up 129.0%, while the annual FY2024 figure was 1.7%, 36.0% down from the prior year.
  • Return on Equity for Q3 2025 was 0.81% at Bionano Genomics, up from 1.59% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.14% in Q2 2021 and bottomed at 2.66% in Q4 2024.
  • The 5-year median for Return on Equity is 0.66% (2023), against an average of 1.12%.
  • The largest YoY upside for Return on Equity was 4035bps in 2021 against a maximum downside of -10845bps in 2021.
  • A 5-year view of Return on Equity shows it stood at 0.21% in 2021, then plummeted by -134bps to 0.5% in 2022, then tumbled by -333bps to 2.16% in 2023, then fell by -23bps to 2.66% in 2024, then soared by 70bps to 0.81% in 2025.
  • Per Business Quant, the three most recent readings for BNGO's Return on Equity are 0.81% (Q3 2025), 1.59% (Q2 2025), and 2.0% (Q1 2025).